These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 25272094)

  • 1. Examining the Time to Improvement of Sleep Interference With Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy and Postherpetic Neuralgia.
    Parsons B; Emir B; Knapp L
    Am J Ther; 2015; 22(4):257-68. PubMed ID: 25272094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.
    Vinik A; Emir B; Parsons B; Cheung R
    Pain Med; 2014 Apr; 15(4):661-70. PubMed ID: 24330406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
    Sharma U; Griesing T; Emir B; Young JP
    Am J Ther; 2010; 17(6):577-85. PubMed ID: 20393345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.
    Arnold LM; McCarberg BH; Clair AG; Whalen E; Thomas N; Jorga A; Pauer L; Vissing R; Park PW
    Postgrad Med; 2017 Nov; 129(8):921-933. PubMed ID: 28967801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.
    Vinik A; Emir B; Cheung R; Whalen E
    Clin Ther; 2013 May; 35(5):612-23. PubMed ID: 23541708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
    Roth T; van Seventer R; Murphy TK
    Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
    Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
    Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.
    Ogawa S; Satoh J; Arakawa A; Yoshiyama T; Suzuki M
    Drug Saf; 2012 Oct; 35(10):793-806. PubMed ID: 22967187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
    Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
    Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
    Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking.
    Huffman C; Stacey BR; Tuchman M; Burbridge C; Li C; Parsons B; Pauer L; Scavone JM; Behar R; Yurkewicz L
    Clin J Pain; 2015 Nov; 31(11):946-58. PubMed ID: 25565583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions: A Double-Blind Crossover Study.
    Raskin P; Huffman C; Yurkewicz L; Pauer L; Scavone JM; Yang R; Parsons B
    Clin J Pain; 2016 Mar; 32(3):203-10. PubMed ID: 25968451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the Time to Therapeutic Effect of Pregabalin in Spinal Cord Injury Patients With Neuropathic Pain.
    Cardenas DD; Emir B; Parsons B
    Clin Ther; 2015 May; 37(5):1081-90. PubMed ID: 25850879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.